{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:41:29Z","timestamp":1759455689646,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1053\/ajkd.2003.50096","type":"journal-article","created":{"date-parts":[[2008,3,20]],"date-time":"2008-03-20T21:29:29Z","timestamp":1206048569000},"page":"S104-S107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S","title":["Renal osteodystrophy: Role of calcimimetics"],"prefix":"10.1053","volume":"41","author":[{"given":"Walter H.","family":"H\u00f6rl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ajkd.2003.50096_bib1","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/ndt\/17.5.723","article-title":"Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia","volume":"17","author":"Locatelli","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50096_bib2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.V95859","article-title":"Nocturnal hemodialysis: Three-year experience","volume":"9","author":"Pierratos","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2003.50096_bib3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/ndt\/15.4.460","article-title":"What's new in vitamin D for the nephrologist?","volume":"15","author":"Schroeder","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50096_bib4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"key":"10.1053\/ajkd.2003.50096_bib5","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/ndt\/13.8.1923","article-title":"Tricking the parathyroid gland with novel calcimimetic agents","volume":"13","author":"Nemeth","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50096_bib6","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1046\/j.1523-1755.1999.00432.x","article-title":"Aluminum is a weak agonist for the calcium-sensing receptor","volume":"55","author":"Spurney","year":"1999","journal-title":"Kidney Int"},{"issue":"suppl 5","key":"10.1053\/ajkd.2003.50096_bib7","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1093\/ndt\/15.suppl_5.30","article-title":"Management of disturbed calcium metabolism in uraemic patients: 3. Potential perspectives\u2014Calcimimetics","volume":"15","author":"Sch\u00f6mig","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50096_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ndt\/17.2.204","article-title":"Calcimimetic agents and secondary hyperparathyroidism: Treatment and prevention","volume":"17","author":"Goodman","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50096_bib9","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199711203372104","article-title":"Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism","volume":"337","author":"Silverberg","year":"1997","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1053\/ajkd.2003.50096_bib10","first-page":"S303","article-title":"The effect of the calcimimetic AMG 073 in patients with hypercalcemia and primary hyperparathyroidism (PHPT)","volume":"16","author":"Shoback","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"suppl 1","key":"10.1053\/ajkd.2003.50096_bib11","first-page":"S163","article-title":"The calcimimetic AMG 073 reduces serum calcium (Ca) in patients with primary hyperparathyroidism (PHPT)","volume":"16","author":"Peacock","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1053\/ajkd.2003.50096_bib12","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1172\/JCI119851","article-title":"The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor","volume":"100","author":"Wada","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1053\/ajkd.2003.50096_bib13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1523-1755.1998.00782.x","article-title":"NPS R-568 halts or reverses osteitis fibrosa in uremic rats","volume":"53","author":"Wada","year":"1998","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50096_bib14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1523-1755.1998.00735.x","article-title":"A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure","volume":"53","author":"Antonsen","year":"1998","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50096_bib15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1523-1755.2000.00183.x","article-title":"A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism","volume":"58","author":"Goodman","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50096_bib16","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/jcem.83.4.4726","article-title":"Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent","volume":"83","author":"Collins","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/ajkd.2003.50096_bib17","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","article-title":"The calcimimetic agent AMG 073 lowers plasma hormone levels in hemodialysis patients with secondary hyperparathyroidism","volume":"13","author":"Goodman","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2003.50096_bib18","first-page":"764A","article-title":"Short-term treatment of secondary hyperparathyroidism (SHPT) with the calcimimetic agent AMG 073","volume":"12","author":"Dr\u00fceke","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2003.50096_bib19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1523-1755.2003.00720.x","article-title":"The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism","volume":"63","author":"Lindberg","year":"2003","journal-title":"Kidney Int"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638603500749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638603500749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:19:04Z","timestamp":1759454344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638603500749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0272638603500749"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2003.50096","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2003,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal osteodystrophy: Role of calcimimetics","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/ajkd.2003.50096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}